Navigation Links
Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
Date:6/28/2012

(PRWEB) June 28, 2012

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates provide free online informational resources that deal with the potential dangers of using certain prescription medications, hereby alerts the public that an Actos bladder cancer lawsuit has been filed in Louisiana by a woman who alleges that her use of this diabetes medication led to her contracting bladder cancer.

Specifically, the case has been assigned a case number of 6:12-cv-1701 and it names several defendants in the action. These defendants include Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Co. The case was filed on June 14th in the U.S. District Court for the Western District of Louisiana and is assigned to Judge Rebecca Doherty.

This Actos bladder cancer lawsuit alleges that the plaintiff used Actos between the years of 2004 and 2007. The plaintiff was diagnosed with bladder cancer in 2006, and she alleges that the prolonged use of Actos is what led to this diagnosis. As a result of this diagnosis, the plaintiff alleges that she has incurred damages that include past and future medical costs, past and future pain and suffering, past and future emotional distress and the loss of companionship with her spouse.

Actos is a diabetes medication that is prescribed for people to help them treat their symptoms associated with type 2 diabetes, and in recent years the medication has been banned in both France and Germany and the United States Food and Drug Administration has required warnings to be published on the labels of this medication that alert its users of the potential risks involving bladder cancer for those who use it for a prolonged period of time.

About the Consumer Justice Foundation    

The Consumer Justice Foundation, whose Web site can be found at http://www.consumerjusticefoundation.com, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9650623.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
2. Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
3. Chemo + Radiation Best for Bladder Cancer, Study Finds
4. Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer
5. Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers
6. Study Ties Secondhand Smoke to Bladder Irritation in Kids
7. Vitamin D + TB vaccine: Allies in fight against bladder cancer?
8. Surgical sling reduces risk of weakened bladder control after prolapse surgery, U-M study says
9. Study Suggests Vaccine May Help Kids With Brain Cancer
10. New Stool Test Might Aid in Early Detection of Colon Cancer
11. Study reveals how cancer drug causes diabetic-like state
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & ... by Moonlight to raise money for the American Heart Association Heart Walk. Teams of ... will work together to keep their treadmills moving for 5 hours. Treadmills will start ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... ... presenting the latest in wound care advancements to physician colleagues, skilled nursing facility ... is titled, "Navigating the Treacherous Waters of Wound Care." , "At many of ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
Breaking Medicine Technology: